Nutex Health (NUTX) Stock Price, News & Analysis

Company Overview

Nutex Health Inc. (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings. Nutex Health also uses an affiliated physician network and technology-enabled care coordination model to connect clinical services across its facilities and support value-based healthcare delivery.

The company is headquartered in Houston, Texas, and serves patients through healthcare locations in several U.S. states, with a significant presence in Texas. Nutex Health traces its origins to a physician-founded healthcare model and has expanded through the development and operation of micro-hospitals and related medical practices. Dr. Tom Vo is the company’s co-founder, chairman and chief executive officer.

Key Stats

• Today's Range: $205.00 to $222.00
• 50-Day Range: $140.49 to $220.11
• 52-Week Range: $83.99 to $224.28
• Volume: 208,919 shs
• Average Volume: 152,242 shs
• Market Capitalization: $1.51 billion
• P/E Ratio: 8.64
• Dividend Yield: N/A
• Price Target: $317.50
• Consensus Rating: Buy

Nutex Health Stock Analysis - MarketRank™

Nutex Health scored higher than 79% of companies evaluated by MarketBeat, and ranked 155th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Buy

Consensus Rating

Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Nutex Health has a consensus price target of $317.50, representing about 44.2% upside from its current price of $220.11.

Amount of Analyst Coverage

Nutex Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.06%

Earnings Growth

Earnings for Nutex Health are expected to grow by 4.06% in the coming year, from $27.58 to $28.70 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nutex Health is 8.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nutex Health is 8.64, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 276.12.

Price to Book Value per Share Ratio

Nutex Health has a P/B Ratio of 3.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

32.58% of the float of Nutex Health has been sold short.

Short Interest Ratio / Days to Cover

Nutex Health has a short interest ratio ("days to cover") of 7.52.

Change versus previous month

Short interest in Nutex Health has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nutex Health does not currently pay a dividend.

Dividend Growth

Nutex Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.69

News Sentiment

Nutex Health has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Nutex Health this week, compared to 4 articles on an average week.

Search Interest

8 people have searched for NUTX on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.

MarketBeat Follows

9 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Nutex Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,493.00 in company stock.

Percentage Held by Insiders

44.68% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.32% of the stock of Nutex Health is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/27/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NASDAQ:NUTX
• CIK: 1479681
• Web: www.nutexhealth.com
• Phone: (713) 660-0557
• Fax: 631-670-6780
• Employees: 944
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Nutex Health: $317.50
• High Price Target: $325.00
• Low Price Target: $310.00
• Potential Upside/Downside: +44.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $25.47
• Trailing P/E Ratio: 8.64
• Forward P/E Ratio: 7.98
• P/E Growth: N/A
• Net Income: $70.79 million
• Net Margins: 21.25%
• Pretax Margin: 40.57%
• Return on Equity: 39.74%
• Return on Assets: 18.91%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 5.00
• Quick Ratio: 4.96

Sales & Book Value

• Annual Sales: $875.26 million
• Price / Sales: 1.72
• Cash Flow: $12.91 per share
• Price / Cash Flow: 17.05
• Book Value: $59.88 per share
• Price / Book: 3.68

Miscellaneous

• Outstanding Shares: 6,850,000
• Free Float: 3,788,000
• Market Cap: $1.51 billion
• Optionable: Not Optionable
• Beta: 0.28